BridgeMD
New treatment option for Opioid Use Disorder
Official title Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
ClinicalTrials.gov ID: NCT07169409
What this study is testing
What is Telemedicine Buprenorphine Treatment?
Telemedicine Buprenorphine Treatment is an investigational medicine, being studied as a potential treatment for opioid use disorder.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Our primary objective is to evaluate the ability of Boulder Care's telehealth-platform to create the necessary paradigmatic shift in Opioid Use Disorder (OUD) treatment to reach vulnerable populations, with targets that support both equitable and culturally-specific OUD treatment as well as business profitability.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- History of Opioid Use Disorder (OUD)
- Starting OUD treatment with buprenorphine, or within 45 days of starting or restarting this medication
- Speak and understand English
You likely can't join if
- History of allergic reaction to buprenorphine
- Plans to move out of a Boulder Care-affiliated state site in the next 12 months (precluding continuation of care)
- Untreated mental or medical health conditions that, in the opinion of the participant, would preclude study participation
The study team makes the final eligibility decision.
Where it's taking place
- Portland, Oregon, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Portland, Oregon, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.